Renal Neoplasms with Concurrent Castleman-Like Regional Lymphadenopathy.

IF 0.9 4区 医学 Q4 PATHOLOGY
Alcino Gama, Ruoji Zhou, Ivan De La Riva-Morales, Jeffrey Sosman, Bogdan Isaila, Qing C Chen, Xiaoqi Lin, Bonnie Choy, Yi-Hua Chen, Ximing J Yang
{"title":"Renal Neoplasms with Concurrent Castleman-Like Regional Lymphadenopathy.","authors":"Alcino Gama, Ruoji Zhou, Ivan De La Riva-Morales, Jeffrey Sosman, Bogdan Isaila, Qing C Chen, Xiaoqi Lin, Bonnie Choy, Yi-Hua Chen, Ximing J Yang","doi":"10.1177/10668969241271421","DOIUrl":null,"url":null,"abstract":"<p><p>IntroductionRenal cell neoplasms are known to be associated with paraneoplastic syndromes, and the association with Castleman-like regional lymphadenopathy has been rarely reported. We aim to characterize the association between renal neoplasms and Castleman-like lymphadenopathy.MethodsA search for renal neoplasms with concurrent Castleman-like lymphadenopathy in one single medical institution from 2000 to 2023 resulted in 4 specimens. A literature search for \"Castleman\" and \"renal neoplasm\" resulted in 8 reports. Patients' demographics, clinical presentation, gross and histologic features, results of ancillary studies, treatment, and follow-up were evaluated.ResultsOur patients included 3 men and 1 woman, with a mean age of 60 years. Four different subtypes of renal neoplasms were diagnosed, including clear cell renal cell carcinoma (RCC), papillary RCC, chromophobe RCC, and mucinous cystadenoma of the renal pelvis. For Castleman-like regional lymphadenopathy, 2 were plasma-cell predominant, and 2 were hyaline-vascular. After a median follow-up of 84 months, all patients were alive with no recurrence or progression of Castleman-like features following nephrectomies.ConclusionCastleman-like regional lymphadenopathy should be considered in patients with renal tumors and lymphadenopathy. Although more prevalent in clear cell RCC, it can be also associated with other renal neoplasms. The concurrent lymphadenopathy was remitted following the renal tumor resections.</p>","PeriodicalId":14416,"journal":{"name":"International Journal of Surgical Pathology","volume":" ","pages":"557-564"},"PeriodicalIF":0.9000,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Surgical Pathology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/10668969241271421","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/8/30 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"PATHOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

IntroductionRenal cell neoplasms are known to be associated with paraneoplastic syndromes, and the association with Castleman-like regional lymphadenopathy has been rarely reported. We aim to characterize the association between renal neoplasms and Castleman-like lymphadenopathy.MethodsA search for renal neoplasms with concurrent Castleman-like lymphadenopathy in one single medical institution from 2000 to 2023 resulted in 4 specimens. A literature search for "Castleman" and "renal neoplasm" resulted in 8 reports. Patients' demographics, clinical presentation, gross and histologic features, results of ancillary studies, treatment, and follow-up were evaluated.ResultsOur patients included 3 men and 1 woman, with a mean age of 60 years. Four different subtypes of renal neoplasms were diagnosed, including clear cell renal cell carcinoma (RCC), papillary RCC, chromophobe RCC, and mucinous cystadenoma of the renal pelvis. For Castleman-like regional lymphadenopathy, 2 were plasma-cell predominant, and 2 were hyaline-vascular. After a median follow-up of 84 months, all patients were alive with no recurrence or progression of Castleman-like features following nephrectomies.ConclusionCastleman-like regional lymphadenopathy should be considered in patients with renal tumors and lymphadenopathy. Although more prevalent in clear cell RCC, it can be also associated with other renal neoplasms. The concurrent lymphadenopathy was remitted following the renal tumor resections.

并发卡斯特曼样区域淋巴腺病的肾肿瘤
简介众所周知,肾细胞瘤与副肿瘤综合征有关,而与卡斯特曼样区域淋巴结病有关的报道却很少。我们旨在描述肾肿瘤与卡斯特曼样淋巴结病之间的关联:方法:在一家医疗机构检索 2000 年至 2023 年期间并发 Castleman 样淋巴结病的肾肿瘤,共获得 4 份标本。以 "Castleman "和 "肾肿瘤 "为关键词进行文献检索,共获得 8 篇报道。我们对患者的人口统计学、临床表现、大体和组织学特征、辅助检查结果、治疗和随访进行了评估:我们的患者包括 3 名男性和 1 名女性,平均年龄为 60 岁。诊断出四种不同亚型的肾肿瘤,包括透明细胞肾细胞癌(RCC)、乳头状肾细胞癌(RCC)、嗜色细胞肾细胞癌(RCC)和肾盂粘液性囊腺瘤。在 Castleman 样区域淋巴结病中,2 例以浆细胞为主,2 例为透明血管性。中位随访84个月后,所有患者均存活,肾切除术后无复发或卡斯特曼样特征进展:结论:患有肾肿瘤和淋巴结病的患者应考虑卡斯特曼样区域淋巴结病。结论:患有肾肿瘤和淋巴结病的患者应考虑卡斯特曼样区域淋巴结病,虽然这种病在透明细胞RCC中更为常见,但也可能与其他肾肿瘤有关。肾肿瘤切除术后,并发淋巴结病得到了缓解。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
2.10
自引率
0.00%
发文量
198
审稿时长
1 months
期刊介绍: International Journal of Surgical Pathology (IJSP) is a peer-reviewed journal published eight times a year, which offers original research and observations covering all major organ systems, timely reviews of new techniques and procedures, discussions of controversies in surgical pathology, case reports, and images in pathology. This journal is a member of the Committee on Publication Ethics (COPE).
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信